Clinical Trials Logo

Clinical Trial Summary

It has been shown, that subjects susceptible to high altitude pulmonary edema (HAPE)are characterized by an abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in normoxia. This abnormal rise of pulmonary artery pressure has also been observed in about 10 % of otherwise healthy subjects without prior altitude exposure. The aim of the study is to investigate the susceptibility to HAPE in unacclimatized subjects with abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in normoxia after rapid ascent to high altitude (4559 m).


Clinical Trial Description

n/a


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT00559442
Study type Interventional
Source Heidelberg University
Contact
Status Completed
Phase N/A
Start date June 2007
Completion date July 2011

See also
  Status Clinical Trial Phase
Terminated NCT03490916 - Effect of Acetazolamide on Subclinical High-Altitude Pulmonary Edema Detected by Lung Ultrasonography Phase 4
Completed NCT00627965 - Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness Phase 4
Recruiting NCT04288219 - Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary Edema N/A
Active, not recruiting NCT01565603 - Sleep and Cerebral Responses to High Altitude N/A
Completed NCT00274430 - Prevention of High Altitude Pulmonary Edema Phase 1/Phase 2
Recruiting NCT06039475 - RISK FACTORS ASSOCIATED WITH HIGH ALTITUDE SICKNESS: A CASE-CONTROL STUDY
Completed NCT04186598 - Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema N/A
Recruiting NCT01698619 - Hemodynamic Changes in Altitude Adaptation N/A
Not yet recruiting NCT04710953 - Comparison of CPAP and Gamow Bag Ventilation to Treat HAPE N/A